Tag Archives: Germany&#039s

Palantir to offer cancer analytics under JV deal with Germany's Merck

((This NOV 19 story corrects to show Merck is Palantir’s exclusive partner within the JV, not for all of Palantir’s healthcare activities, paragraph 11)) FILE PHOTO: Merck CEO Stefan Oschmann delivers a speech during the celebrations of the 350th anniversary of German pharmaceuticals company Merck at the Merck headquarters in Darmstadt, Germany, May 3 ,2018.… Read More »